Could an ancient herb keep breast cancer at bay?

NCT ID NCT07601113

Completed Disease control Sponsor: Kun-Ming Rau Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study follows 66 women with stage II/III breast cancer who received a natural supplement called PG2 (from astragalus root) alongside their standard chemotherapy. Researchers want to see if PG2 helps delay cancer recurrence or spread, and whether it improves survival. The goal is to learn if adding this immune-boosting therapy can offer long-term benefits for early breast cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE II/III BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SURVIVAL

Contacts and locations

Locations

Chang Gung Memorial Hospital, Kaohsiung Branch

Kaohsiung City, Taiwan
Chang Gung Memorial Hospital, Linkou Branch

Taoyuan City, Taiwan
Chang Gung Memorial Hospital, Lovers Lake branch

Keelung, Taiwan
Chang Gung Memorial Hospital, Taipei Branch

Taipei, Taiwan
E-Da Cancer Hospital

Kaohsiung City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.